JP Morgan conference call, more results
You can call for a replay of JP Morgan CC from Nov 15, about 40 minutes long: 800 879 6719. On this call, INFI revealed that one responder on IPI 549 with mesothelioma is on drug now for 15 months with a 42% reduction in tumor volume. This is a remarkable result in a very difficult to treat tumor. IPI 549 is well tolerated which bodes well in the upcoming combination studies due in 2018 with Optivo. Market cap is around 100 million and with essentially no debt. High insider buying, cash of about half the market cap. What is not to like. They also mentioned on the CC that many patients had stable disease including very sick patient with colorectal cancer who had previously progressed after just 2 months on chemo prior to IPI 549 treatment. GLTA